Firstly, we found that NSCLC cells with stably silencing of PRKCA (shP-1 and shP-2) showed markedly impaired cell viability and clonogenic capacity (Supplementary Figure 4B-5D), suggesting a strong oncogenic potential of PRKCA in NSCLC. Here, PRKCA is linked to non-small cell lung carcinoma.